Citations

Showing 10 of 108104 citations.

Hearing Outcomes in Conservatively Managed Vestibular Schwannoma Patients With Serviceable Hearing
Hunter, Jacob B. , Dowling, Eric M. , Lohse, Christine M. , O’Connell, Brendan P., Tombers, Nicole M. , Lees, Katherine A. , Thompson, Reid, Haynes, David S. , Carlson, Matthew L. , Dowling, Eric M., Hunter, Jacob B

Mayo Clinic

Otology & Neurotology | July 23, 2018 | Volume: 39 | Issue: 8 | Pages: e704-e711

10.1097/mao.0000000000001914 | PMID 30036205 Get It

Objective: To characterize the risk of progression to nonserviceable hearing in patients with sporadic vestibular schwannomas (VS) who elect initial observation. Study Design: Retrospective case series. Setting: Two tertiary care centers. Patients: VS patients with serviceable hearing who underwent at least two audiograms and two MRI studies before intervention or loss to follow-up. Main outcome measure(s): Serviceable hearing, defined as the pure tone average ≤ 50 dB HL and word recognition score ≥ 50%. Results: Four-hundred sixty-six patients (median age of 57 yr and median tumor diameter of 7.3 mm) had serviceable hearing at presentation and were followed for a median of 2.3 years (IQR 1.0 – 4.0). Kaplan–Meier estimated rates of maintaining serviceable hearing (95% CI; number still at risk) at 1, 3, 5, 7, and 10 years following diagnosis were 94% (91–96; 357), 77% (73–82; 172), 66% (60–73; 81), 56% (49–65; 31), and 44% (33–59; 10), respectively. Each 10-dB increase in pure-tone averages at diagnosis was associated with a 2-fold increased likelihood of developing nonserviceable hearing (hazard ratio 2.07; p < 0.001). Each 10% decrease in word recognition score was associated with a 1.5-fold increased likelihood of developing nonserviceable hearing (hazard ratio 1.48; p < 0.001). Conclusions: Among patients with sporadic VS, good baseline word recognition score and low pure-tone average are jointly associated with maintenance of serviceable hearing. These data may be used to guide patient counseling and optimize management.
A 56‐year‐old woman with blindness and mental status changes
Reichard, R. Ross , Vaubel, Rachael A.

Mayo Clinic

Brain Pathology | July 23, 2018 | Volume: 28 | Issue: 4 | Pages: 583-584

10.1111/bpa.12623 | PMID 30133867 Get It

Editorial: Arthritis Gene Therapy Using Interleukin‐1 Receptor Antagonist
Evans, Christopher H. , Evans, Christopher

Mayo Clinic

Arthritis & Rheumatology | July 23, 2018 | Volume: 70 | Issue: 11 | Pages: 1699-1701

10.1002/art.40675 | PMID 30035385 Get It

Old Remedies to Heal the Liver: Novel Effects of Digoxin in Hepatic Sterile Inflammation
Arab, Juan Pablo , Arab, Juan P, Arab, Juan P , Arrese, Marco

Mayo Clinic

Hepatology | July 23, 2018 | Volume: 69 | Issue: 2 | Pages: 904-906

10.1002/hep.30188 | PMID 30033594 Get It

Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta‐analysis
Hilal, Talal , Almader‐Douglas, Diana , Rosenthal, Allison , Reeder, Craig B. , Jain, Tania , Almader-Douglas, Diana, Rosenthal, Allison , Jain, Tania , Hilal, Talal , Wang, Zhen

Mayo Clinic

American Journal of Hematology | July 23, 2018 | Volume: 93 | Issue: 10 | Pages: 1220-1226

10.1002/ajh.25226 | PMID 30033656 Get It

AbstractMantle cell lymphoma is characterized by relapse and progressive disease, despite initial response to chemoimmunotherapy. We conducted a systematic review and meta‐analysis to determine the efficacy of rituximab maintenance (RM) therapy in patients with mantle cell lymphoma. We searched PubMed, Embase and Cochrane Central Register of Controlled Trials from database inception through November 1, 2017. Only full‐text articles were included. Prespecified data elements were extracted from each trial. Outcomes of interest included progression‐free survival (PFS) and overall survival (OS). The overall effect was pooled using the Der Simonian‐Laird random effects model. Three randomized controlled trials and four observational studies met our inclusion criteria and were identified in the analyses. Six studies compared RM therapy to observation, and one compared RM therapy to interferon alfa. Meta‐analysis evaluating outcomes of patients treated after ASCT revealed that RM improved for both PFS (HR = 0.33, 95% CI = 0.23‐0.49) and OS (HR of death = 0.35, 95% CI = 0.17‐0.69). A second meta‐analysis of studies evaluating outcomes of patients who are ASCT‐ineligible treated with anthracycline‐based induction therapy revealed that RM improved PFS (HR = 0.38, 95% CI = 0.25‐0.58). There is a paucity of data on the role of RM in ASCT‐ineligible patients and those with relapsed disease. Overall, RM therapy appears to improve PFS and OS in previously untreated patients with mantle cell lymphoma who undergo induction chemoimmunotherapy followed by ASCT.
Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?
Langlais, Blake, Geyer, Holly L. , Scherber, Robyn M. , Dueck, Amylou C. , Langlais, Blake T., Geyer, Holly, Dueck, A. C. , Mesa, Ruben A.

Mayo Clinic

Leukemia & Lymphoma | July 23, 2018 | Volume: 60 | Issue: 2 | Pages: 402-408

10.1080/10428194.2018.1480768 | PMID 30033837 Get It

Daratumumab for the treatment of AL amyloidosis
Sidiqi, M Hasib , Gertz, Morie A. , Gertz, Morie A , Sidiqi, M Hasib

Mayo Clinic

Leukemia & Lymphoma | July 23, 2018 | Volume: 60 | Issue: 2 | Pages: 295-301

10.1080/10428194.2018.1485914 | PMID 30033840 Get It

Survival and Prognostic Factors in Patients With Solid Pseudopapillary Neoplasms of the Pancreas
Huffman, Brandon M. , Westin, Gustavo Figueiredo Marcondes, Alsidawi, Samer , Nagorney, David M. , Hálfdánarson, Þorvarður R. , Mahipal, Amit , Mahipal, Amit , Halfdanarson, Thorvardur R , Alberts, Steven R.

Mayo Clinic

Pancreas | July 23, 2018 | Volume: 47 | Issue: 8 | Pages: 1003-1007

10.1097/mpa.0000000000001112 | PMID 30036214 Get It

Objectives Prognostic factors for solid pseudopapillary neoplasms (SPN) of the pancreas have been incompletely defined in the literature. We aimed to use the National Cancer Database to describe survival and characterize prognostic factors in patients with pancreatic pseudopapillary neoplasms. Methods We identified 304 patients with pancreatic SPN diagnosed between 2004 and 2012 using the National Cancer Database. All patients were included in the survival analysis. Kaplan-Meier method, χ 2 , and log-rank tests were used for statistical analysis. Cox proportional hazard regression model was used for multivariate analysis. Results The median age at diagnosis was 36.5 years. Eighty-five percent of patients were female, 69% were white, and 25% were black. Metastases were observed in 5% of patients. Median tumor size was 5.1 cm. Ninety-two percent of patients underwent primary tumor resection. At 60 months, 98% of patients who underwent resection were alive, and 40% who did not undergo resection were alive. On multivariate analysis, female sex, resection of primary tumor, and absence of metastasis were correlated with improved survival. Conclusions Patients with SPN who undergo resection have an excellent survival at 5 years. Surgery should be considered in all patients with this diagnosis.
A novel anesthesiologist‐led multidisciplinary model for evaluating high‐risk surgical patients at a comprehensive cancer center
Sroka, Raymond, Al‐Hadidi, Danna, Nurkin, Steven, Quinn, Timothy D., Gabriel, Emmanuel M, Gabriel, Emmanuel , Urman, Richard D

Mayo Clinic

Journal of Healthcare Risk Management | July 23, 2018 | Volume: 38 | Issue: 3 | Pages: 12-23

10.1002/jhrm.21326 | PMID 30033650 Get It

Abstract The objective of this retrospective analysis was to describe the development and implementation of an anesthesiologist‐led multidisciplinary committee to evaluate high‐risk surgical patients in order to improve surgical appropriateness. The study was conducted in an anesthesia preoperative evaluation clinic at an academic comprehensive cancer center. One hundred sixty‐seven high‐risk surgical patients with cancer‐related diagnoses were evaluated and discussed at a High‐Risk Committee (HRC) meeting to determine surgical appropriateness and optimize perioperative care. The HRC is an anesthesiologist‐led model for multidisciplinary review of high‐risk patients developed at Roswell Park Comprehensive Cancer Center. The group of high‐risk patients in which surgery was not performed had, on average, a greater percentage of hypertension, smoking history, dyspnea, heart failure, chronic obstructive pulmonary disease, diabetes, renal failure, and sleep apnea than the group in whom surgery was performed. Only one of 107 high‐risk patients who had surgery died within the first 30 days after surgery. A smaller percentage of patients died in the group that had surgery versus the group in which surgery was canceled. For all patients discussed by the HRC, the mortality was less than 2% within the first 30 days after the HRC.
Outcomes in patients with cor triatriatum sinister
Fuchs, Margaret , Connolly, Heidi M. , Said, Sameh M. , Egbe, Alexander C. , Fuchs, Margaret M

Mayo Clinic

Congenital Heart Disease | July 23, 2018 | Volume: 13 | Issue: 4 | Pages: 628-632

10.1111/chd.12624 | PMID 30033682 Get It